Skip to main navigation Skip to search Skip to main content

Medical therapy for chronic refractory angina

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Medical therapy is the cornerstone of treatment for patients with chronic refractory angina, as it is across the entire spectrum of vascular disease. As part of a comprehensive risk modification program, including exercise, diet, and appropriate revascularization, optimal medical therapy offers significant benefit in reducing symptoms of ischemic heart disease and improving long-term prognosis. Indeed, current medical regimens, far superior to those offered only a decade ago, afford patients with refractory angina a marked survival benefit. Newer agents have demonstrated a marked symptomatic benefit, as well. This chapter will explore the importance of optimal medical therapy in improving prognosis, as well as details potential for imparting a much needed boost to quality of life and symptom amelioration.

Original languageEnglish
Title of host publicationCoronary Artery Disease
Subtitle of host publicationNew Approaches without Traditional Revascularization
PublisherSpringer-Verlag London Ltd
Pages39-51
Number of pages13
Volume9781846287121
ISBN (Electronic)9781846287121
ISBN (Print)1846284600, 9781846284601
DOIs
Publication statusPublished - 1 Apr 2012
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Medical therapy for chronic refractory angina'. Together they form a unique fingerprint.

Cite this